Xperi (NYSE:XPER - Get Free Report) was downgraded by equities researchers at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a research note issued on Saturday, Wall Street Zen reports.
XPER has been the topic of a number of other research reports. Weiss Ratings raised Xperi from a "sell (d-)" rating to a "sell (d)" rating in a research report on Monday, November 9th. Rosenblatt Securities reaffirmed a "buy" rating and issued a $10.00 price objective on shares of Xperi in a research report on Thursday, August 6th. Finally, BWS Financial reiterated a "buy" rating and set a $12.00 target price on shares of Xperi in a research note on Friday, August 7th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Xperi presently has an average rating of "Hold" and a consensus price target of $11.00.
Check Out Our Latest Research Report on Xperi
Xperi Stock Performance
Shares of XPER opened at $5.31 on Friday. The firm has a 50-day moving average of $5.45 and a 200-day moving average of $6.43. Xperi has a one year low of $4.91 and a one year high of $8.75. The company has a market cap of $259.23 million, a PE ratio of -7.81 and a beta of 1.40. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.38 and a quick ratio of 2.38.
Xperi (NYSE:XPER - Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The company reported $0.24 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.07. The company had revenue of $113.95 million for the quarter, compared to analyst estimates of $111.47 million. Xperi had a negative net margin of 6.89% and a positive return on equity of 4.43%. As a group, equities analysts forecast that Xperi will post 0.57 earnings per share for the current year.
Hedge Funds Weigh In On Xperi
Large investors have recently modified their holdings of the stock. The Manufacturers Life Insurance Company boosted its holdings in shares of Xperi by 24.7% during the second quarter. The Manufacturers Life Insurance Company now owns 3,092,416 shares of the company's stock worth $25,451,000 after acquiring an additional 613,428 shares during the period. TSP Capital Management Group LLC grew its position in shares of Xperi by 29.2% in the third quarter. TSP Capital Management Group LLC now owns 1,135,706 shares of the company's stock valued at $6,258,000 after purchasing an additional 256,630 shares during the last quarter. Wellington Management Group LLP grew its position in shares of Xperi by 11.4% in the second quarter. Wellington Management Group LLP now owns 2,483,786 shares of the company's stock valued at $20,442,000 after purchasing an additional 255,082 shares during the last quarter. Segall Bryant & Hamill LLC acquired a new position in shares of Xperi in the first quarter valued at approximately $2,313,000. Finally, Algert Global LLC increased its stake in shares of Xperi by 29.2% during the second quarter. Algert Global LLC now owns 438,668 shares of the company's stock worth $3,610,000 after purchasing an additional 99,021 shares during the period. 94.28% of the stock is owned by institutional investors.
About Xperi
(
Get Free Report)
Xperi develops technology for entertainment and connected devices, serving markets that include television, consumer electronics and automotive. Its products and platforms help manufacturers and media companies deliver content, audio and interactive experiences across connected screens and vehicles. The company's brands and offerings include TiVo, whose products support television discovery and streaming, and DTS, which provides audio technologies. Xperi also develops HD Radio and automotive solutions such as DTS AutoStage, as well as services for smart TVs and other consumer devices.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xperi, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xperi wasn't on the list.
While Xperi currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.